Genzyme Calls for Research Proposals for Renal Innovations Program

02-Nov-2004

Genzyme Corp. is seeking proposals from nephrology researchers for funding under the Genzyme Renal Innovations Program (GRIP). Over the past three years GRIP has awarded 26 grants, funding more than $3.5 million in innovative research projects that advance medical knowledge and practice related to kidney disease.

Genzyme outlined the proposal criteria at the American Society of Nephrology (ASN) meeting in St. Louis last week. An independent medical review board of leaders in nephrology will evaluate the proposals and award grants for a period of one to three years. The board has requested proposals in four key areas: new targets in renal disease, mechanisms of renal fibrosis, podocyte biology and epithelial cell apoptosis.

This week, following the ASN meeting, the previous grant recipients will gather to share their research findings.

"The Genzyme Renal Innovations Program has generated some very promising research in many different areas of nephrology," said Robert Guiberteau, vice president, renal clinical strategy and business development, Genzyme Corp. "Genzyme is dedicated to continuing its support of this program, which we hope will lead to improvements in the medical care of people with kidney disease."

Proposals must be submitted by March 31, 2005. Recipients will be announced at the European Renal Association/European Dialysis and Transplant Association Annual Congress in June 2005.

https://www.bionity.com/en/news/40614/genzyme-calls-for-research-proposals-for-renal-innovations-program.html